Scientific News: A Look At Boston Scientific (BSX) Valuation After The Penumbra Acquisition And Recent Shareholder Returns

Choose a language:

Science Daily Reports

Details: Written by Bing News Search Results; Category: Science Daily Reports; Published: 16 April 2026; Created: 16 April 2026; Last Updated: 16 April 2026

Boston Scientific overview and recent trading context Boston Scientific (BSX) develops medical devices across MedSurg and Cardiovascular segments. Its shares have recently faced pressure, with ...
Original Image Link
Source:finance.yahoo.com

Posted: 2026-04-15 04:32:00

Get Full News Story On Bing Science News Network

Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

More News From This Category
Scientific News: AAAS letter informs April 2026 House hearing on state of scientific publishing
Thu, 16 Apr 2026 04:07:16 +0000

In the letter, AAAS highlights rising challenges to research integrity including paper mills, predatory journals, and the misuse of artificial intelligence tools.
Original Image Link
Source:www.aaas.org

Scientific News: An AI-authored paper just passed peer review. The scientific community isn’t ready
Thu, 16 Apr 2026 04:07:16 +0000

The arrival of AI-generated research papers marks a turning point that could radically accelerate discovery—or drown it in automated mediocrity ...
Original Image Link
Source:www.scientificamerican.com

Scientific News: Eurofins Scientific divests electrical testing business in €575M deal with UL Solutions
Tue, 14 Apr 2026 22:07:15 +0000

Eurofins Scientific (ERFSF) has signed an agreement to sell its Electrical & Electronic Testing business, MET Labs, to UL Solutions Inc. for €575 million, on a cash and debt-free basis. MET Labs is ...
Original Image Link
Source:www.msn.com

Scientific News: Citi Reiterates Buy rating for Boston Scientific (BSX)
Tue, 14 Apr 2026 19:07:15 +0000

Boston Scientific Corp. (NYSE:BSX) is one of the 7 oversold stocks to buy with double-digit ROE growth. On April 7, Joanne Wuensch from Citi reduced the price target on Boston Scientific Corp.
Original Image Link
Source:finance.yahoo.com

Related Bing News Results